Location: United States, California, South San Francisco
Investors 1
| Date | Name | Website |
| - | Horizon Te... | horizontec... |
Mentions in press and media 24
| Date | Title | Description | Source |
| 12.03.2024 | Opioid Use Disorder Market to Reach USD 6.15 Billion by 2030... | Opioid Use Disorder (OUD) Market Opioid Use Disorder Market Analysis, Industry Trends and Growth Out... | einpresswi... |
| 02.02.2022 | Titan Pharmaceuticals Announces Pricing of $5.5 Million Regi... | SOUTH SAN FRANCISCO, Calif., Feb. 2, 2022 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP)... | marketscre... |
| 21.12.2021 | Titan Pharmaceuticals to Explore Strategic Alternatives | SOUTH SAN FRANCISCO, Calif., Dec. 21, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP... | marketscre... |
| 09.11.2021 | Sustained Anti-Pruritic Effect Of Titan's TP-2021 Implant Re... | SOUTH SAN FRANCISCO, Calif., Nov. 8, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP)... | marketscre... |
| 05.11.2021 | Titan Announces Upcoming TP-2021 Implant Data Presentation a... | SOUTH SAN FRANCISCO, Calif., Nov. 5, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. announced that... | marketscre... |
| 25.10.2021 | Titan Pharmaceuticals : Receives Funding to Develop Combinat... | SOUTH SAN FRANCISCO, Calif., Oct. 25, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP... | marketscre... |
| 12.10.2021 | Titan Pharmaceuticals : and MUSC FRD Enter Into Research and... | SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP... | marketscre... |
| 23.06.2021 | Titan Announces Positive Results from the First Studies of T... | prnewswire... | |
| 23.06.2021 | Titan Pharmaceuticals : Announces Positive Results from the ... | SOUTH SAN FRANCISCO, Calif., June 23, 2021 /PRNewswire/ -- Titan Pharmaceuticals, Inc. (NASDAQ: TTNP... | marketscre... |
| 31.03.2021 | Titan Pharmaceuticals Announces Filing Of 2020 Annual Report... | prnewswire... |
Show more